CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis

118

CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis

Tags:

Previous Article

The maternal microbiome during pregnancy impacts offspring’s stem cells in mice

CAR-T cells for multiple sclerosis

Related Posts

The rare-to-common disease journey: a winding road to new therapies

The rare-to-common disease journey: a winding road to n...

130

The exocyst subunit EXOC2 regulates the toxicity of expanded GGGGCC repeats in C9ORF72-ALS/FTD

The exocyst subunit EXOC2 regulates the toxicity of exp...

105

Constructing language: a framework for explaining acquisition

Constructing language: a framework for explaining acqui...

123